Elsevier

Journal of Psychiatric Research

Volume 91, August 2017, Pages 105-110
Journal of Psychiatric Research

Correcting delayed circadian phase with bright light therapy predicts improvement in ADHD symptoms: A pilot study

https://doi.org/10.1016/j.jpsychires.2017.03.004Get rights and content

Abstract

Attention-deficit/hyperactivity disorder (ADHD) is a common condition with comorbid insomnia reported in >70% of children and adults. These patients demonstrate delays in sleep-wake rhythms, nocturnal rise in melatonin, and early morning rise in cortisol. Given that standard psychopharmacologic treatments for ADHD often do not completely control symptoms in participants with circadian rhythm delay, we sought to test whether bright light therapy (BLT) advances circadian rhythms and further reduces ADHD symptoms over standard treatments. In addition to standard of care, participants with ADHD diagnosis underwent 1 week of baseline assessment followed by 2-weeks of 30-min morning 10,000-lux BLT beginning 3 h after mid-sleep time. Participants minimized overhead light after 4 p.m., wore an actigraphy watch, and recorded BLT time on daily sleep logs. Dim Light Melatonin Onset (DLMO) was assessed at baseline and after 2-week treatment. ADHD symptoms were measured by the ADHD-Rating Scales (ADHD-RS). BLT significantly advanced the phase of DLMO by 31 min [mean time (SEM), 20:36 (0:21) advanced to 20:05 (0:20)] and mid-sleep time by 57 min [4:37 (0:22) advanced to 3:40 (0:16); paired t-tests, p = 0.002 and 0.004, respectively). Phase advances (in DLMO or mid-sleep time) were significantly correlated with decreased ADHD-RS total scores (p = 0.027 and 0.044) and Hyperactive-Impulsive sub-scores (p = 0.014 and 0.013, respectively). Actigraphy analysis for a subset of 8 participants with significant DLMO phase advance revealed no significant changes in total sleep time, sleep efficiency, wake after sleep onset, or percent wake during sleep interval. This is the first successful use of BLT for advancing melatonin phase and improving ADHD symptoms in adults. BLT may be a complementary treatment for both delayed sleep timing and ADHD symptoms in adults.

Introduction

Attention-deficit/hyperactivity disorder (ADHD) is characterized by problems with attention, impulsivity and over-activity. The syndrome affects 4.5% of adults (Kessler et al., 2006), resulting in an estimated $3.6 billion loss in work costs (Birnbaum et al., 2005). More than 70% of children and adults with ADHD also report insomnia (Fargason et al., 2013; Fargason et al., 2011, Gruber et al., 2012, Kessler et al., 2006, Van der Heijden et al., 2005, Van Veen et al., 2010). The sleep disturbance is often due to circadian rhythm disruption characterized by delayed sleep in both children and adults, and psychiatric disorders, including ADHD, have been found to be associated with phase delay (Gamble et al., 2013, Lewy et al., 2006). Patients with ADHD demonstrate delays in: sleep-wake rhythms, nocturnal rise in melatonin, and early morning rise in cortisol (Baird et al., 2012, Novakova et al., 2011, Van der Heijden et al., 2005, Van Veen et al., 2010). Despite the significant comorbidity of ADHD and sleep disturbances, common treatment regimens such as stimulants do not address these sleep problems, and hence fail to achieve full symptom control of core ADHD symptoms. In fact, treatment with long-acting stimulant medications can shorten sleep duration, delay sleep-onset, and reduce circadian amplitude, all of which may negatively impact executive function and attention (Morash-Conway et al., 2016, Ironside et al., 2010). Additionally, circadian dysfunction and resultant disturbed sleep are associated with learning problems (Kopasz et al., 2010, Van der Heijden et al., 2005), poor driving performance (Anderson and Horne, 2013, Ftouni et al., 2013), depression (Lall et al., 2012, McCall et al., 2010, Taylor et al., 2005), and occupational dysfunction (Adan et al., 2012, Dagan, 2002), all of which are ADHD co-morbidities. As a result, there is an urgent need to develop non-pharmacological approaches to treat sleep disturbances, which often worsen attention deficits and impulsive behavior in adults with ADHD diagnosis.

When presented at the appropriate time-of-day, bright light therapy (BLT) has shown success for the treatment of a variety of sleep conditions (Crowley et al., 2004, Revell and Eastman, 2005, Smith et al., 2009, Wilhelmsen-Langeland et al., 2013, Wilhelmsen-Langeland et al., 2014, Wirz-Justice et al., 2013). A key characteristic of the endogenous circadian clock is the ability to synchronize 24-h rhythms to the light-dark cycle, such that early evening light exposure shifts wake-time to a later time (phase delay) while early morning light exposure shifts wake-time to an earlier time (phase advance) (Klein and Weller, 1970, Tamarkin et al., 1979). Well-timed light exposure can be used to shift sleep-wake rhythms earlier or later before/after transmeridian travel or before/after a change in shift schedule (Honma et al., 1991, Revell and Eastman, 2005). Therapeutic use of BLT in the morning to extend the light exposure period during the winter (mimicking summer-like conditions) alleviates depression in seasonal affective disorder (Burgess et al., 2004, Lieverse et al., 2011, Terman, 2006). Insomnia associated with delayed sleep phase syndrome is improved after administration of morning BLT (30 min) in a randomized controlled trial (Wilhelmsen-Langeland et al., 2013). Finally, combining BLT with total sleep deprivation and sleep phase advance (‘Triple Chronotherapy’) significantly reduced depression and suicidal ideation in an open-label, adjunctive therapy trial (Sahlem et al., 2014).

Our prior clinical trial demonstrated that delayed sleep timing (circadian phase delay) predicts ADHD symptom severity and that standard psychopharmacologic treatments for ADHD often do not completely control symptoms in participants with circadian rhythm delay (Gamble et al., 2013). These findings have not been translated into practical treatment applications such as BLT in patients with ADHD diagnosis. Thus, the aim of our study was to use BLT to manipulate the well-validated endogenous clock phase marker dim-light melatonin onset (DLMO) to explore the relationship between delayed circadian phase and ADHD symptoms. Understanding this relationship may highlight complementary or alternative mechanisms for clinical treatment.

Section snippets

Participants

In this study, all participants were between ages 19 and 64 and met the DSM-IV-TR criteria for ADHD (more restrictive than DSM-5 criteria) with a mean age of 36.1 ± 13.2. Patients taking psychoactive medication for any condition other than ADHD or who were diagnosed with a co-morbid psychiatric disorder, sleep apnea, light-sensitive skin condition, ocular disorder or were shift-workers were excluded. Participants were recruited from the UAB Outpatient Psychiatry clinic during November

Results

A total of 19 participants completed the protocol. DLMO data from 3 participants were not analyzable due to low melatonin levels (N = 2) and light exposure during collection (N = 1). As predicted, BLT advanced the phase of DLMO by 31 min [mean time (SEM), 20:36 (0:21) advanced to 20:05 (0:20)] and mid-sleep time by 57 min [4:37 (0:22) advanced to 3:40 (0:16); paired t-tests, p = 0.002 and 0.004, respectively; Fig. 2). The net effect of these two outcomes produced a significantly more narrow

Discussion

Despite the association of delayed sleep timing with ADHD symptom severity and the inadequacy of standard psychopharmacologic treatments for ADHD in participants with circadian rhythm delay (Gamble et al., 2013), the effectiveness of BLT as a treatment for patients with ADHD diagnosis has not previously been assessed. As hypothesized, BLT advanced DLMO and mid-sleep in adults with ADHD, and these advances were associated with decreased ADHD symptoms, including hyperactive-impulsive symptoms.

Conclusion

This open-label pilot study suggests that BLT is a feasible treatment for adults with ADHD and may be a successful complementary treatment for delayed sleep timing and symptoms of ADHD in adults. A randomized, placebo-controlled trial is needed to assess futher treatment effects.

Financial/material support

UAB Health Services Foundation General Endowment Fund Actigraphy Program and UAB Psychiatry departmental funds (Birmingham, AL, USA).

Disclosures

All authors have no direct or indirect affiliations or financial interests in connection with the content of this paper to disclose.

Acknowledgments

We would like to thank Dr. James Meador-Woodruff, M.D. (UAB Department of Psychiatry) for general support for this project, and Dr. Richard Shelton, M.D. (UAB Department of Psychiatry) for critical review of the study and for editing this letter. Drs. Meador-Woodruff and Shelton have no financial disclosures for this project.

References (51)

  • S. Bioulac et al.

    Excessive daytime sleepiness in adult patients with ADHD as measured by the Maintenance of Wakefulness Test, an electrophysiologic measure

    Curr. Psychiatry Rep.

    (2015)
  • H.G. Birnbaum et al.

    Costs of attention deficit-hyperactivity disorder (ADHD) in the US: excess costs of persons with ADHD and their family members in 2000

    Curr. Med. Res. Opin.

    (2005)
  • K. Brookes et al.

    The analysis of 51 genes in DSM-IV combined type attention deficit hyperactivity disorder: association signals in DRD4, DAT1 and 16 other genes

    Mol. Psychiatry

    (2006)
  • H.J. Burgess et al.

    Bright light therapy for winter depression–is phase advancing beneficial?

    Chronobiol Int.

    (2004)
  • Y.L. Cao et al.

    Association of CLOCK gene T3111C polymorphism with attention deficit hyperactivity disorder and related sleep disturbances in children

    Zhongguo Dang Dai Er Ke Za Zhi

    (2012)
  • S.J. Crowley et al.

    Complete or partial circadian re-entrainment improves performance, alertness, and mood during night-shift work

    Sleep

    (2004)
  • Y. Dagan

    Circadian rhythm sleep disorders (CRSD) in psychiatry–a review

    Isr. J. psychiatry Relat. Sci.

    (2002)
  • G.J. DuPaul et al.

    ADHD Rating Scale IV: Checklists, Norms, and Clinical Interpretation

    (1998)
  • R.E. Fargason et al.

    Adults with ADHD-without insomnia history have subclinical sleep disturbance but not circadian delay: an ADHD phenotype?

    J. Atten. Disord.

    (2013)
  • R.E. Fargason et al.

    Ramelteon for insomnia related to attention-deficit/hyperactivity disorder (ADHD)

    Psychopharmacol. Bull.

    (2011)
  • S. Ftouni et al.

    Objective and subjective measures of sleepiness, and their associations with on-road driving events in shift workers

    J. Sleep. Res.

    (2013)
  • K.L. Gamble et al.

    Delayed sleep timing and symptoms in adults with attention-deficit/hyperactivity disorder: a controlled actigraphy study

    Chronobiol Int.

    (2013)
  • R. Gruber et al.

    Contributions of circadian tendencies and behavioral problems to sleep onset problems of children with ADHD

    BMC Psychiatry

    (2012)
  • K. Honma et al.

    Bright lights accelerate the re-entrainment of circadian clock to 8-hour phase-advance shift of sleep-wake schedule: 1) Circadian rhythms in rectal temperature and plasma melatonin level

    Jpn. J. Psychiatry Neurol.

    (1991)
  • L. Imeraj et al.

    Time-of-day effects in arousal: disrupted diurnal cortisol profiles in children with ADHD

    J. Child. Psycholo Psychiatry

    (2012)
  • Cited by (42)

    • Sleep and circadian rhythm actigraphy measures, mood instability and impulsivity: A systematic review

      2021, Journal of Psychiatric Research
      Citation Excerpt :

      Later sleep phase estimated by actigraphy-derived midsleep was positively associated with BRI scores in healthy young adults (Kuula et al., 2018) and BIS-11 in healthy students (McGowan and Coogan, 2018). Further, earlier midsleep times resulting from bright light therapy were negatively associated with ADHD-RS scores and hyperactivity-impulsivity sub-scores in adults with ADHD (Fargason et al., 2017). Consistent sources of bias across the ten studies related to sample selection and attrition (Supplementary Table 4).

    • Review: Identification and Management of Circadian Rhythm Sleep Disorders as a Transdiagnostic Feature in Child and Adolescent Psychiatry

      2021, Journal of the American Academy of Child and Adolescent Psychiatry
      Citation Excerpt :

      Also, synchronization to daylight is compromised during the daytime by photophobia leading to the wearing of sunglasses in adults with ADHD.70 Congruent with this concept, 2 pilot studies in which morning bright light therapy was applied in adults with ADHD demonstrated an advanced circadian phase and subsequent improvements in ADHD symptoms.63,71 Consistent with this, Arns et al.72–74 observed a strong geographical correlation between higher sunlight intensity and a lower prevalence of ADHD across the United States and in other countries.

    View all citing articles on Scopus
    View full text